Skip to main content

Day: September 1, 2022

Vigil Neuroscience to Present at 2022 Morgan Stanley Global Healthcare Conference

CAMBRIDGE, Mass., Sept. 01, 2022 (GLOBE NEWSWIRE) — Vigil Neuroscience, Inc. (Nasdaq: VIGL), a clinical-stage biotechnology company committed to harnessing the power of microglia for the treatment of neurodegenerative diseases, today announced that members of the management team will participate in a fireside chat at the 2022 Morgan Stanley Global Healthcare Conference on Monday, September 12, 2022, at 4:50 p.m. ET. To access a live webcast of this presentation, please visit “Events & Presentations” in the “Investors” section of the Vigil website at www.vigilneuro.com.   An archived replay will be available there for approximately 90 days following the presentation. About Vigil NeuroscienceVigil Neuroscience is a microglia-focused therapeutics company focused on developing treatments for both rare and common neurodegenerative...

Continue reading

First Advantage Expands Global Footprint, Opens New Office in Kraków, Poland

Company Selects Emerging Tech Hub to Support Growing Global PresenceFirst Advantage Opens New Office in Kraków Company continues to expand its global footprint.KRAKÓW, Poland and ATLANTA, Sept. 01, 2022 (GLOBE NEWSWIRE) — First Advantage Corporation (NASDAQ: FA), a leading global provider of HR technology solutions for screening, verifications, safety, and compliance, today announced the opening of a new office in Kraków, Poland. With a reputation as an emerging tech hub in Europe, the expansion into Kraków furthers First Advantage’s commitment to developing and delivering innovative solutions and insights that help customers manage risk and hire the best talent across the globe. To better serve its global client base, First Advantage is currently hiring technology, customer care, and operations positions for the modern facility...

Continue reading

Navigator Holdings Ltd. Announces Membership of Maritime Anti-Corruption Network

LONDON and NEW YORK, Sept. 01, 2022 (GLOBE NEWSWIRE) — Navigator Holdings Ltd. (“Navigator”) (NYSE: NVGS), the owner and operator of the world’s largest fleet of handysize liquefied gas carriers, announced today that it has successfully joined the Maritime Anti-Corruption Network (“MACN”), a global business network dedicated to a maritime industry free of corruption. Mads Peter Zacho, Navigator’s CEO, commented: “Conducting business ethically is fundamental to the identity and core values of Navigator. Joining the Maritime Anti-Corruption Network demonstrates our commitment to carrying out business with honesty and integrity across all of our commercial activities. “MACN’s vision to remove corruption from the maritime industry aligns strongly with our own values which aim for a fairer, more transparent and sustainable maritime...

Continue reading

Sutro Biopharma to Present at the 2022 Wells Fargo Healthcare Conference

SOUTH SAN FRANCISCO, Calif., Sept. 01, 2022 (GLOBE NEWSWIRE) — Sutro Biopharma, Inc. (Sutro or the Company) (NASDAQ: STRO), a clinical-stage oncology company pioneering site-specific and novel-format antibody drug conjugates (ADCs), today announced that Bill Newell, Chief Executive Officer, will present at the 2022 Wells Fargo Healthcare Conference on Friday, September 9, 2022, at 10:25 a.m. ET / 7:25 a.m. PT in Boston. The presentation will be accessible through the News & Events page of the Investor Relations section of the company’s website at www.sutrobio.com. An archived replay will be available for at least 30 days after the event. About Sutro Biopharma Sutro Biopharma, Inc., headquartered in South San Francisco, is a clinical-stage oncology company pioneering site-specific and novel-format antibody drug conjugates (ADCs)....

Continue reading

Green Thumb Industries Announces Conference Participation for September 2022

CHICAGO and VANCOUVER, British Columbia, Sept. 01, 2022 (GLOBE NEWSWIRE) — Green Thumb Industries Inc. (Green Thumb) (CSE: GTII) (OTCQX: GTBIF), a leading national cannabis consumer packaged goods company and owner of RISE Dispensaries, today announced its executive team will participate in the following conferences in September 2022: 3rd Annual Needham Cannabis Conference (Virtual), September 7, 2022: Management will participate in one-on-one meetings. Wolfe Research Fall Consumer Conference (Virtual), September 22, 2022: Management will participate in one-on-one meetings. About Green Thumb Industries:Green Thumb Industries Inc. (“Green Thumb”), a national cannabis consumer packaged goods company and retailer, promotes well-being through the power of cannabis while giving back to the communities in which it serves. Green Thumb...

Continue reading

First Advantage Expands Global Footprint, Opens New Office in Kraków, Poland

Company Selects Emerging Tech Hub to Support Growing Global Presence KRAKÓW, Poland and ATLANTA, Sept. 01, 2022 (GLOBE NEWSWIRE) — First Advantage Corporation (NASDAQ: FA), a leading global provider of HR technology solutions for screening, verifications, safety, and compliance, today announced the opening of a new office in Kraków, Poland. With a reputation as an emerging tech hub in Europe, the expansion into Kraków furthers First Advantage’s commitment to developing and delivering innovative solutions and insights that help customers manage risk and hire the best talent across the globe. To better serve its global client base, First Advantage is currently hiring technology, customer care, and operations positions for the modern facility located in the heart of downtown at High Five Office ul. Pawia 9 Kraków. “We are excited...

Continue reading

Good Supply Launches New High-Potency Product Drop and Unveils Exclusive Orange Frost Live Resin

TORONTO, Sept. 01, 2022 (GLOBE NEWSWIRE) — Tilray Brands, Inc. (“Tilray” or the “Company”) (Nasdaq: TLRY; TSX: TLRY), a leading global cannabis-lifestyle and consumer packaged goods company inspiring and empowering the worldwide community to live their very best life today announced the expansion of Good Supply’s award-winning cannabis portfolio. The brand’s latest product drop includes new high-potency concentrates Jean Guy Badder, Hash Bats in Pineapple Express, and Orange Frost Live Resin, available for a limited time. “Good Supply’s iconic strains provide a framework through which consumers can find consistency while exploring a variety of new formats,” says Michelle Morin, Good Supply’s brand manager. “By offering our strains in new categories such as concentrates, it provides a novel...

Continue reading

Galera Appoints Eugene P. Kennedy, M.D., F.A.C.S., as Chief Medical Officer

MALVERN, Pa., Sept. 01, 2022 (GLOBE NEWSWIRE) — Galera Therapeutics, Inc. (Nasdaq: GRTX), a clinical-stage biopharmaceutical company focused on developing and commercializing a pipeline of novel, proprietary therapeutics that have the potential to transform radiotherapy in cancer, today announced the appointment of Eugene P. Kennedy, M.D., F.A.C.S., as Chief Medical Officer (CMO). Dr. Kennedy is a renowned Johns Hopkins-trained surgical oncologist and former Chief of Pancreatic and Hepatobiliary Surgery at Thomas Jefferson University with over 15 years’ experience in clinical development and biopharma leadership. He will succeed Jon T. Holmlund, M.D., who will retire at the end of this year. In the interim, Dr. Kennedy and Dr. Holmlund will work together closely to ensure a smooth and successful transition, with particular focus...

Continue reading

TELA Bio to Participate in Upcoming Investor Conferences

MALVERN, Pa., Sept. 01, 2022 (GLOBE NEWSWIRE) — TELA Bio, Inc. (“TELA”), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions that optimize clinical outcomes by prioritizing the preservation and restoration of the patient’s own anatomy, today announced that it will participate in two upcoming investor conferences. TELA Bio’s management is scheduled to present virtually at the H.C. Wainwright Annual Global Investment Conference. Interested parties can access the archived webcast at ir.telabio.com on Monday, September 12th, 2022, at 7:00am ET. TELA Bio’s management will also be participating in the Lake Street BIG6 1×1 Conference on Wednesday, September 14th, 2022. About TELA Bio, Inc. TELA Bio, Inc. (NASDAQ: TELA) is a commercial-stage medical technology...

Continue reading

ALX Oncology Announces Upcoming Investor Conference Participation

SOUTH SAN FRANCISCO, Calif., Sept. 01, 2022 (GLOBE NEWSWIRE) — ALX Oncology Holdings Inc., (“ALX Oncology”) (Nasdaq: ALXO) a clinical-stage immuno-oncology company developing therapies that block the CD47 checkpoint pathway, today announced that management will participate in two upcoming investor conferences. Citi’s 17th Annual BioPharma Conference Format: Investor meetings Date: Wednesday, September 7 Location: Boston, MA H.C. Wainwright 24th Annual Global Investment ConferenceFormat: Fireside chat with analyst, Swayampakula RamakanthDate: Monday, September 12 Time: 7:00 AM Eastern Time Location: VirtualWebcast link: Available here A live webcast of the H.C. Wainwright fireside chat is available here and can be accessed by visiting the Investors section of ALX Oncology’s website at www.alxoncology.com and selecting Events...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.